Cite
VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission.
MLA
Azagury, M., et al. “VP-16, Cisplatin, Doxorubicin, and Bleomycin in Metastatic Merkel Cell Carcinoma. Report of a Case with Long-Term Remission.” American Journal of Clinical Oncology, vol. 16, no. 2, Apr. 1993, pp. 102–04. EBSCOhost, https://doi.org/10.1097/00000421-199304000-00003.
APA
Azagury, M., Chevallier, B., Atlan, D., Graic, Y., Dayot, J. P., & Thomine, E. (1993). VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission. American Journal of Clinical Oncology, 16(2), 102–104. https://doi.org/10.1097/00000421-199304000-00003
Chicago
Azagury, M, B Chevallier, D Atlan, Y Graic, J P Dayot, and E Thomine. 1993. “VP-16, Cisplatin, Doxorubicin, and Bleomycin in Metastatic Merkel Cell Carcinoma. Report of a Case with Long-Term Remission.” American Journal of Clinical Oncology 16 (2): 102–4. doi:10.1097/00000421-199304000-00003.